Millennium Management
DCPH

Millennium Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Millennium Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-42,800
Closed -$701K – 7052
2022
Q4 		$701K Buy
42,800
+8,100
+23% +$132K ﹤0.01% 4479
2022
Q3 		$642K Buy
+34,700
New +$545K ﹤0.01% 4734
2021
Q4 		– Sell
-30,100
Closed -$1.02M – 7528
2021
Q3 		$1.02M Buy
30,100
+10,100
+51% +$322K ﹤0.01% 4647
2021
Q2 		$732K Buy
20,000
+13,700
+217% +$530K ﹤0.01% 4956
2021
Q1 		$282K Sell
6,300
-60,700
-91% -$2.83M ﹤0.01% 5256
2020
Q4 		$3.82M Buy
67,000
+63,000
+1,575% +$3.73M ﹤0.01% 2708
2020
Q3 		$205 Sell
4,000
-6,000
-60% -$294K ﹤0.01% 4053
2020
Q2 		$597K Hold
10,000
– – ﹤0.01% 3294
2020
Q1 		$412K Buy
+10,000
New +$555K ﹤0.01% 2999

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Millennium Management's DCPH Position: Q2 2024 in Review

Millennium Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 797,100 shares — an estimated $12.5M sold.

Millennium Management first reported a position in DCPH in Q3 2017 and held it in 27 quarters. The position peaked at $91.6M in Q3 2019. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Millennium Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Millennium Management sold 797,100 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $12.5M.
  • Millennium Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 27 quarters.
  • Millennium Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $91.6M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.